New Gates Foundation Grant to Support TB Drug R&D

May 25, 2006

The Bill & Melinda Gates Foundation has announced a new $104 million grant to the Global Alliance for TB Drug Development in order to:

Advance moxifloxacin into Phase III trials, with the goal of demonstrating its effectiveness for TB by 2010;
Pursue nine pre-clinical projects and identify the best of these compounds for clinical studies;
Work with policymakers, TB treatment providers and advocates to ensure that new TB drugs will be adopted and made accessible in developing countries;
Analyze drug market conditions and compliance issues to ensure the rapid adoption of a new drug regimen once it is shown to be effective.

Topics

HIV

World Health Organization

HIV

World Health Organization

DISCLAIMER & PERMISSIONS

CGD's publications reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions. You may use and disseminate CGD's publications under these conditions.